Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases

被引:37
作者
Lenarcic, B
Krishnan, G
Borukhovich, R
Ruck, B
Turk, V
Moczydlowski, E
机构
[1] Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA
关键词
D O I
10.1074/jbc.M001406200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type 1 domain of thyroglobulin is a protein module (Thyr-1) that occurs in a variety of secreted and membrane proteins. Several examples of Thyr-1 modules have been previously identified as inhibitors of the papain family of cysteine proteinases, Saxiphilin is a neurotoxin-binding protein from bullfrog and a homolog of transferrin with a pair of such Thyr-1 modules located in the N-lobe. Saxiphilin is now characterized as a potent inhibitor of three cysteine proteinases as follows: papain, human cathepsin B, and cathepsin L, The stoichiometry of enzyme inhibition reveals that both Thyr-1 domains of saxiphilin inhibit papain (apparent K-i = 1.72 naa), but only one of these domains inhibits cathepsin B (K-i = 1.67 nM) and cathepsin L (K-i = 0.02 nM). Physical association of saxiphilin and papain blocked from turnover at the active-site cysteine residue can be detected by cross-linking with glutaraldehyde. The rate of association of saxiphilin and cathepsin B is strongly pH-dependent with an optimum at pH 5.2, reflecting control by at least two H+-titratable groups. These results further demonstrate that various Thyr-1 domains are selective inhibitors of cysteine proteinases with utility in the study of protein interactions and degradation.
引用
收藏
页码:15572 / 15577
页数:6
相关论文
共 45 条
  • [1] STRUCTURE OF HUMAN LACTOFERRIN - CRYSTALLOGRAPHIC STRUCTURE-ANALYSIS AND REFINEMENT AT 2.8-A RESOLUTION
    ANDERSON, BF
    BAKER, HM
    NORRIS, GE
    RICE, DW
    BAKER, EN
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1989, 209 (04) : 711 - 734
  • [2] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P771
  • [3] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
  • [4] Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L
    Bevec, T
    Stoka, V
    Pungercic, G
    Dolenc, I
    Turk, V
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1331 - 1338
  • [5] INVIVO SIGNIFICANCE OF KINETIC CONSTANTS OF PROTEIN PROTEINASE-INHIBITORS
    BIETH, JG
    [J]. BIOCHEMICAL MEDICINE, 1984, 32 (03): : 387 - 397
  • [6] PURIFICATION OF PAPAIN BY AFFINITY CHROMATOGRAPHY
    BLUMBERG, S
    SCHECHTER, I
    BERGER, A
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1970, 15 (01): : 97 - +
  • [7] COVALENT CHROMATOGRAPHY - PREPARATION OF FULLY ACTIVE PAPAIN FROM DRIED PAPAYA-LATEX
    BROCKLEHURST, K
    CARLSSON, J
    KIERSTAN, MP
    CROOK, EM
    [J]. BIOCHEMICAL JOURNAL, 1973, 133 (03) : 573 - 584
  • [8] CRAIG WS, 1988, METHOD ENZYMOL, V156, P333
  • [9] SAXITOXIN BINDING-SITES IN FROG MYOCARDIAL CYTOSOL
    DOYLE, DD
    WONG, M
    TANAKA, J
    BARR, L
    [J]. SCIENCE, 1982, 215 (4536) : 1117 - 1119
  • [10] FERSHT A, 1984, ENZYME STRUCTURE MEC, P155